Assessment of tumor response to radiation and vascular targeting therapy in mice using quantitative ultrasound spectroscopy

作者: Ahmed El Kaffas , Ali Sadeghi-Naini , Omar Falou , William Tyler Tran , Stephanie Zhou

DOI: 10.1118/1.4926554

关键词: CancerBasic fibroblast growth factorUltrasoundPathologyMedicineCluster of differentiationDosimetrySunitinibRadiation therapyRadiosensitivity

摘要: Purpose: It is now recognized that the tumor vasculature in part responsible for regulating responses to radiation therapy. However, extent which radiation-based vascular damage contributes cell death remains unknown. In this work, quantitative ultrasound spectroscopy (QUS) methods were used investigate acute of tumors treatments. Methods: Tumor xenografts (MDA-MB-231) treated with single doses 2 or 8 Gy alone, combination pharmacological agents modulate radiosensitivity. The midband fit, slope, and 0-MHz intercept QUS parameters obtained from a linear-regression fit averaged power spectrum frequency-dependent backscatter quantify following treatment administration. Power spectrums extracted raw volumetric radio-frequency data before 24 h These have previously been correlated death. Staining using situ end labeling, carbonic anhydrase 9 cluster differentiation 31 sections assess death, oxygenation, distributions, respectively. Results: Results indicate significant parameter increases 3.2 ± 0.3 dBr 5.4 0.5 combined antiangiogenic agent Sunitinib, respectively. contrast, alone demonstrated increase 4.4 at only. Preadministration basic fibroblast growth factor, an endothelial radioprotector, acted minimize response large radiation. Immunohistochemical analysis was general agreement findings; R2 0.9 observed when quantified changes fit. Conclusions: Results presented study confirm linked effect high Overall, previous reports suggesting regulated by vascular-driven response. Data also suggest Sunitinib may enhance radiosensitivity through remodeling process, be sensitive tissue properties associated remodeling. Finally, work demonstrates ability monitor strategies.

参考文章(47)
Randy D’Amico, Liang Lei, Benjamin C Kennedy, Julia Sisti, Victoria Ebiana, Celina Crisman, James G Christensen, Orlando Gil, Steven S Rosenfeld, Peter Canoll, Jeffrey N Bruce, The addition of Sunitinib to radiation delays tumor growth in a murine model of glioblastoma Neurological Research. ,vol. 34, pp. 252- 261 ,(2012) , 10.1179/1743132812Y.0000000005
Gilda G. Hillman, Vinita Singh-Gupta, Hao Zhang, Areen K. Al-Bashir, Yashwanth Katkuri, Meng Li, Christopher K. Yunker, Amit D. Patel, Judith Abrams, E. Mark Haacke, Dynamic contrast-enhanced magnetic resonance imaging of vascular changes induced by sunitinib in papillary renal cell carcinoma xenograft tumors. Neoplasia. ,vol. 11, pp. 910- 920 ,(2009) , 10.1593/NEO.09618
Adriana Haimovitz-Friedman, Carlos Cordon-Cardo, Alan Alfieri, Maureen McLoughlin, Zvi Fuks, Desiree Ehleiter, Jeffery L. Schwartz, Andrew P. Seddon, Roger S. Persaud, Basic Fibroblast Growth Factor Protects Endothelial Cells against Radiation-induced Programmed Cell Death in Vitro and in Vivo Cancer Research. ,vol. 54, pp. 2582- 2590 ,(1994)
Marcus Czabanka, Mara Vinci, Frank Heppner, Axel Ullrich, Peter Vajkoczy, Effects of sunitinib on tumor hemodynamics and delivery of chemotherapy International Journal of Cancer. ,vol. 124, pp. 1293- 1300 ,(2009) , 10.1002/IJC.24019
Sam S. Yoon, Lars Stangenberg, Yoon-Jin Lee, Courtney Rothrock, Jonathan M. Dreyfuss, Kwan-Hyuck Baek, Peter R. Waterman, G. Petur Nielsen, Ralph Weissleder, Umar Mahmood, Peter J. Park, Tyler Jacks, Rebecca D. Dodd, Carolyn J. Fisher, Sandra Ryeom, David G. Kirsch, Efficacy of Sunitinib and Radiotherapy in Genetically Engineered Mouse Model of Soft-Tissue Sarcoma International Journal of Radiation Oncology*Biology*Physics. ,vol. 74, pp. 1207- 1216 ,(2009) , 10.1016/J.IJROBP.2009.02.052
O. Guérin, P. Formento, C. Lo Nigro, P. Hofman, J. L. Fischel, M. C. Etienne-Grimaldi, M. Merlano, J. M. Ferrero, G. Milano, Supra-additive antitumor effect of sunitinib malate (SU11248, Sutent®) combined with docetaxel. A new therapeutic perspective in hormone refractory prostate cancer Journal of Cancer Research and Clinical Oncology. ,vol. 134, pp. 51- 57 ,(2007) , 10.1007/S00432-007-0247-4
Shingo Matsumoto, Keita Saito, Yoichi Takakusagi, Masayuki Matsuo, Jeeva P Munasinghe, Herman D Morris, Martin J Lizak, Hellmut Merkle, Keiji Yasukawa, Nallathamby Devasahayam, Sankaran Suburamanian, James B Mitchell, Murali C Krishna, None, In vivo imaging of tumor physiological, metabolic, and redox changes in response to the anti-angiogenic agent sunitinib: longitudinal assessment to identify transient vascular renormalization. Antioxidants & Redox Signaling. ,vol. 21, pp. 1145- 1155 ,(2014) , 10.1089/ARS.2013.5725
Gilda Gali Hillman, Vinita Singh-Gupta, Areen K. Al-Bashirt, Hao Zhang, Christopher K. Yunker, Amit D. Patel, Seema Sethi, Judith Abrams, E. Mark Haacket, Dynamic contrast-enhanced magnetic resonance imaging of sunitinib-induced vascular changes to schedule chemotherapy in renal cell carcinoma xenograft tumors Translational Oncology. ,vol. 3, pp. 293- 306 ,(2010) , 10.1593/TLO.10136
Gregory J. Czarnota, Role of ultrasound in the detection of apoptosis. European Journal of Nuclear Medicine and Molecular Imaging. ,vol. 32, pp. 622- 622 ,(2005) , 10.1007/S00259-004-1736-1